PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Azoth Analytics (P) Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Azoth Analytics Releases 2015-2020 Global Alzheimer’s Drug Market Report - Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market)
Azoth Analytics Releases 2015-2020 Global Alzheimer’s Drug Market Report

 

NewswireToday - /newswire/ - Delhi, New Delhi, India, 2015/12/11 - Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market).

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Executive Summary

Progressive numbers of neurological disorders along with escalating demand for drugs to control of Alzheimer Disease.

The Global Alzheimer’s Market is growing at a moderate rate over last five years on account of rising expenditure on health care especially neurological disorders among ageing population and escalating role of private and government bodies in empowering R&D measures to avoid degenerative disorders. During 2015-20, Global Alzheimer Disease Market is anticipated to grow at an increased rate on account of robust expansion plans of the increase in medical facilities. Moreover, increase in number of patients suffering from degenerative disorder is further anticipated to boost the Global Alzheimer’s market in the coming years.

According to Azoth Analytics research report,“Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years; By Region; Global Dementia Market)”, global Alzheimer’s market is projected to exhibit a CAGR of over 8.54% during 2015 2020. On the basis of Reisberg Scale, market is categorized by seven stages of Alzheimer. Alzheimer is expected to be cured by Drugs; Exercise and Nutrition. Growth in Alzheimer’s Drug market is anticipated to grow in the next five years. Asia Pacific region dominated the revenue contribution share in 2014 and the region is forecast to continue its domination through 2020. Few of the leading companies operating in Global Alzheimer’s Disease Market include Axovant Sciences Ltd., Biotie Therapies, Acadia Pharmaceuticals, Novartis International AG and many more.

Scope of the Report

The report “Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) - (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years; By Region; Global Dementia Market)” analyzes the following aspects of global Alzheimer’s market:

• Global Alzheimer’s Market Size, Share & Forecast
• Segmental Analysis By Therapeutics, By Diagnostics and Biomarkers, By Imaging Sector, By Patient and By Drugs
• Policy & Regulatory Landscape
• Market Entry Strategies for Domestic/Foreign Players
• Changing Market Trends & Emerging Opportunities
• Competitive Landscape & Strategic Recommendations

1. Global Alzheimer’s Disease Market Size, By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
2. Global Alzheimer’s Disease Market by Therapeutics, By Value (USD Million) 2010-2020F
3. Global Alzheimer’s Market share, By Therapeutics
4. Global Alzheimer’s Disease Market, By Diagnostics and Biomarkers, By Value (USD Billion)
5. Global Alzheimer’s Disease Market, By Imaging Sector, By Value (USD Million)
6. Global Alzheimer’s Disease Market by Disease Modifying Therapeutics Market Size, By Value (USD Million)
7. Global Alzheimer’s Disease Market, By Demographics, By Age < 65, By Volume (Number of patients in million), 2010-2020F
8. Global Alzheimer’s Disease Market, By Demographics, By Age > 65, By Volume (Number of patients in million), 2010-2020F
9. Global Memantine (Nameda) Drug Market Size, By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
10. United States Dementia Disease Market Size, By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
11. Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14
12. U.S. Alzheimer’s Drug RTV-101 Market, By Value & Penetration Rate; 2019-2027 (USD Million)
13. U.S. Alzheimer’s Drug Azeliragon Market, By Value & Penetration Rate, 2019-2027 (USD Million)
14. U.S. Annual Alzheimer’s Death Rates, By Age; 2006-2013
15. U.S. Annual Alzheimer’s Death Rates, By Age; 2006-2013
16. Global Dementia Disease Market Size, By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
17. Global Dementia Disease Market Size, By Volume (Number of Patients In Million), By Region 2014
18. Global Dementia Disease Market Size, By Number of new cases, By Volume (Number of Patients In Million), By Region 2014
19. Asia-Pacific Dementia Disease Market Size, By Volume (Number of Patients In Million), By country 2015E, 2030F, 2050F
20. Global Dementia Disease Market Size, By Volume (Number of Patients In Million), By Region 2014
21. Global Dementia Disease Market Size Low Income Countries, Volume (Number of Patients In Million) 2010-2020F
22. Global Dementia Disease Market Size Low Income Countries, Volume (Number of Patients In Million) 2010-2020F
23. Global Dementia Disease Market Size in Top Ten Countries, Volume (Number of Patients In Million) 2010-2020F
24. Australia Dementia Disease Market Size, By Volume (Number of Patients In Million) 2010-2020F
25. Australia Dementia Disease Market Size, By Volume (Number of Patients In Million) 2010-2020F
26. UK Dementia Market, By Type, 2014 (%)
27. UK Dementia Cost, By Type of Service, 2014 (%)
28. Number of Unpaid Caregivers (In Million)
29. Pfizer Revenue (USD Million) AY 2011-2014
30. Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
31. Pfizer Percentage Revenue, By Business Segment (2014)
32. Pfizer Percentage Revenue, By Geography (2014)
33. Novartis International AG Revenue (USD Million) AY 2011-2014
34. Novartis International AG Percentage Revenue, By Business Segment (2014)
35. Novartis International AG Percentage Revenue, By Geography (2014)
36. Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
37. Axovant Services Ltd. Percentage Revenue, By Business Segment (2014)
38. Axovant Services Ltd. Percentage Revenue, By Geography (2014)
39. Acadia Pharmaceuticals Revenue (USD Million) AY 2011-2014.

About Azoth Analytics (P) Ltd

Our business research and market analysis (azothanalytics.com) helps organizations across different industry verticals solve their business problems. We are always scrupulous about our work and provide customized market research reports revealing the hidden truths on different verticals like pharmaceutical, oil and gas, telecommunications, real estate, logistics, energy, healthcare, technology, FMCG, food & beverages and media sectors.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Azoth Analytics (P) Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Azoth Analytics Releases 2015-2020 Global Alzheimer’s Drug Market Report

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Subhodeep Sen - AzothAnalytics.com 
+91 98 11715635 info[.]azothanalytics.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Azoth Analytics (P) Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Azoth Analytics (P) Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)